Detalles de la búsqueda
1.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594880
2.
Urinary Retention Suggesting Aseptic Meningitis: Meningitis-Retention Syndrome Without Physical Signs of Meningeal Irritation.
Acta Med Okayama
; 77(2): 199-201, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094958
3.
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Int J Clin Oncol
; 27(7): 1139-1144, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534642
4.
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
Invest New Drugs
; 39(2): 530-536, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159674
5.
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer.
Jpn J Clin Oncol
; 51(2): 279-286, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33049757
6.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115855
7.
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
Support Care Cancer
; 29(9): 5237-5244, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649919
8.
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Cancer
; 126(16): 3648-3656, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32484914
9.
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
Oncologist
; 25(4): 306-e618, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297438
10.
Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease.
Heart Vessels
; 35(11): 1483-1493, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444933
11.
Pulmonary Tumor Thrombotic Microangiopathy Induced by Prostate Cancer.
Acta Med Okayama
; 72(3): 309-313, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29926010
12.
Erratum to: Impact of previous thoracic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer.
Jpn J Clin Oncol
; 51(8): 1348, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215885
13.
Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 study.
Respir Investig
; 62(2): 277-283, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38266551
14.
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.
Cancer Med
; 12(14): 14988-14999, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226421
15.
Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426.
Transl Cancer Res
; 12(4): 873-886, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180670
16.
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Sci Rep
; 13(1): 19729, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957228
17.
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Lung Cancer
; 184: 107349, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651927
18.
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.
Ther Adv Med Oncol
; 15: 17588359231177021, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37323187
19.
Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
Acta Oncol
; 51(4): 537-40, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22085375
20.
A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L).
Clin Cancer Res
; 28(5): 893-902, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921023